[Trial of device that is not approved or cleared by the U.S. FDA]
Withheld · NCT07340684
At a glance
- Research payments reported, 2025
- $34,094
- U.S. investigators named
- 0
- Sites paid
- 0
About the trial
- Sponsor
- [Redacted]
- Results posted
- Not yet
From ClinicalTrials.gov, last updated 2026-10-19. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Neurent Medical Limited reported $34,094 in research payments for this study in 2025 (12 payments).
Products named: Neuromark Radiofrequency Console, Neuromark System
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
Sites paid to run it
- $34,094
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.